The ability to differentiate the value of a clear set of observations from the inferences which may be drawn from them is the hallmark of a physician with "good clinical judgment." This type of discernment is also needed for retrospective observational clinical studies. Prospective controlled trials should investigate a hypothesis which has some a priori reason to support it, but those concerned with retrospective analyses have to be satisfied with generating new ideas to be tested, A good recent example of this process comes from several studies which have shown that patients with colorectal cancer survive longer if they are not given blood tranfusions at the time of their surgery.T he research workers have not only suggested that this finding may be causally related but also considered the possibility that their observation might be an epiphenomenon: it might be that in each histopathological stage those patients needing blood transfusions had an intrinsically worse prognosis than those patients in the same stage who did not need them. Possibly a cumulative effect in the population as a whole has simply identified those patients with an inherently poorer outlook. The size of the difference in prognosis suggests, however, that this observation is not just a statistical statement of minor clinical importance but may be one of the crucial factors determining outcome, with an up to fourfold effect on tumour recurrence between the two groups' and a large influence on survival.2 Furthermore, their conclusion that perioperative blood transfusion has an independent influence on prognosis is supported by the statistical methods used-namely, the log rank and Cox proportional hazard regression analyses, which allow the more usual single variate analysis to be followed by multivariate adjustments made for all significant covariance simultaneously.'
Yet if it is assumed that the differences observed were directly related to blood transfusion the biological basis for this outcome may be difficult to explain. A simple analogy to the beneficial effects of blood transfusion in association with kidney transplantation is attractive. That would suggest that the transfused blood (probably the white blood cells) results in immunosuppression, releasing the tumour to metastasise and grow.
Several different types of immunological events have been ©t BRITISH MEDICAL JOURNAL 1985. All reproduction rights reserved. described after blood transfusion in patients given renal transplants. One possibility is that the beneficial effects of blood transfusion on the survival of kidney grafts may be attributed to clonal deletion and not to immunosuppression. 6 Terasaki has argued that "multiple transfusions are postula ed to hyperimmunise patients. Upon transplantation, a vigorous anamnestic response occurs. High dose immunosuppression given at transplantation kills or inactivates clones of reactive cells. In non-transfused patients, the peak immunosuppression at transplantation is given prematurely before rejection occurs." Others have suggested a process of patient selection which affects renal graft survival when blood transfusion is given before transplantation.7 After transfusion, and once broad spectrum HLA antibodies have developed, a patient will be difficult to match. Should a match be found, however, then the chances of graft survival will be enhanced. Setting the scene for these ideas some 40 years ago, Medawar clearly showed that blood transfusion is an immunostimulant in a "normal" host.8
At present, therefore, immunologists cannot readily explain either the effects of blood transfusion after renal transplantation or its deleterious effects on prognosis after resection for cure in patients with colorectal cancer. Possible answers to some of the questions might be obtained by a randomised controlled trial in which immunological tests could be carried out in parallel with randomly assigned clinical management.
For reasons argued elsewhere, however,9 and because of the well known "Hawthorne effect" associated with "open" studies, there seems little possibility of a truly controlled investigation of a patient population similar to that in the retrospective studies. The published data will persuade most surgeons with a responsible interest in colonic resection for cancer to correct preoperative anaemia or iron deficiency with haematinics, to redouble their efforts to prevent surgical bleeding, to resist the temptation to use blood transfusions of one or two units, and possibly to consider prior autoblood donation if preoperative anaemia is not a problem. ' 3 To suggest that we should attempt randomised controlled trials for all these items before accepting their therapeutic value would be absurd. Possibly a trial of "washed" versus "unwashed" packed red cells might be justifiable. I suggest, VOLUME 291 NO 6499 PAGE 841 however, that the real value of any such trials is that they encourage standardisation of management methods, including all the items mentioned above.
This conclusion might disappoint a trial technocrat, but it should be accepted as part of the difficulty and frustration inherent in clinical research. Furthermore, the scientific committees of grant giving bodies need to acknowledge more readily that, by its very nature, this type of clinical investigational work is not "clean" (in a scientific sense). Imaginative proposals should be encouraged to help generate reliable information based on some standardisation of treatment patterns, both operative and perioperative, which might help the outcome of the increasing numbers of patients requiring bowel resection. In any event, until it can be shown that blood transfusion is not harmful in the long term to patients with large bowel cancer, it seems reasonable to avoid it whenever possible. L P FIELDING Seventh age itch "Sans teeth, sans eyes, sans taste, sans everything."' Shakespeare knew that blunting of the senses was one of the hallmarks of old age, but there is one exception-itch. All too often it appears or is exaggerated in the elderly.
Pruritus is synonymous with itch but when used as a diagnostic term is applied to patients whose itch is unaccompanied by any visible primary skin disease. Many such elderly patients have little to see on their skins, but excluding a primary skin disorder is not as easy as it might seem since scratching may have caused more than scratch marks. "Prurigo" is an ill defined term which describes the excoriated pink papules which are often seen on itchy skin and which seem to be due to scratching.2 Lichenification-thickened skin looking like Morocco leather-is also due to prolonged scratching and rubbing. Similarly, purpura, broken hairs, and pigmentation may be secondary to repeated trauma.
On the other side of the coin, even the use of a lens will not prevent trained doctors with intact sensory faculties from falling into some common traps. All of us can tell embarrassing stories about missing scabies in clean people, forgetting to ask about infested pets, overlooking underclothes crawling with lice, omitting to check for contact with fibreglass,3 disregarding minor eczema, and failing to appreciate the existence of conditions such as winter itch4 and aquagenic pruritus. 5 Even when these have been considered, however, many elderly patients still have no recognisable skin disease responsible for their itching. Between 16% and 50% of patients investigated for pruritus have an underlying systemic disease. 
